Skip to main content
OpenTrials
Completed

NCT Number: NCT02895451

Behavioral Interventions for Improvement of Adherence at Exercise-based Cardiac Rehabilitation (ECRA)

The purpose of this study is to investigate the effects of an extended behavioral intervention in exercise-based CR for improvement of physical capacity, adherence, psychological and physiological parameters, compared with usual care.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Linkoeping University

Linköping, 58183, Sweden

About this study

Consecutive patients will be included at the coronary care unit (CCU), Linköping University Hospital, Sweden. Physiotherapists ask patients for informed consent at the CCU and book an appointment at the exercise-based CR 2-3 weeks after discharge for baseline tests. After baseline testing patients will be randomized to either extended intervention or routine care. Randomization will be stratified by submaximal exercise capacity. Patients randomized to the extended intervention group receive an additional appointment to a physiotherapist within a week. Thereafter patients in both groups start the exercise-based CR program, including aerobic exercise and resistance exercise, 3 times/week for 16 weeks, according to international guidelines for exercise-based CR.

The extended intervention is based on components from behavioral medicine including: specific goal-setting, self-monitoring and feed-back.

Changes in the endpoint variables will be measured from baseline to first (16 weeks at end of intervention) and second (12 months after index event) follow-up visits.

Sample size calculations are based on previous clinical data from a similar exercise-based CR setting (n=50) on differences in aerobic exercise capacity measured by submaximal exercise test (watts) before vs after finished exercise-based CR. With a power of 80% and a two-sided significance level of p<0.05 and least mean difference at 10 watts (SD 20 watts) and a calculated loss of follow-up of 20%, the estimated sample size is 160 patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Primary care event due to coronary artery disease and/or percutaneous coronary intervention (PCI) at the coronary care unit, Linköping University hospital
  • Age <75 years

Exclusion criteria

  • Serious physical or psychological disease interfering with participation in exercise-based CR
  • Inability to understand the Swedish language

Treatment and study plan

Extended behavioral intervention

Behavioral

The exercise goal is set in liaison between the patient and the physiotherapist, based on activities and target behaviors that the patient thinks is relevant and important. The patients are asked to self-monitor the defined exercise goal by completing an exercise diary. The exercise diary includes specification of the performed exercise dose (frequency, intensity and duration). The exercise diary is followed up by a physiotherapist every third week by a phone call or a personal meeting. Visual feed-back on the performed dose of exercise is given once by accelerometry. At end of intervention (16 weeks) the patient is offered a follow-up meeting with the physiotherapist to discuss a long-term exercise goal.

Primary outcomes

  1. Change from baseline aerobic exercise capacity (watts) at 4 months

    Time frame: 4 months

    The test is performed on a bicycle ergometer according to the WHO-protocol with an increased workload of 25W every 4.5 minutes.The exercise test is discontinued at Borg RPE 17 and/or dyspnea 7 at Borg´s CR-10 scale.

Secondary outcomes

  1. Adherence to dose of exercise

    Time frame: 4 months

    accelerometer

  2. Adherence to dose in exercise

    Time frame: 4 months

    exercise diary

  3. Change from baseline unilateral isotonic shoulder flexion (repetitions) at 4 months

    Time frame: 4 months

    Muscle endurance test

  4. Change from baseline unilateral isotonic heel lift (repetitions) at 4 months

    Time frame: 4 months

    Muscle endurance test

  5. Change from baseline anxiety score at 4 months

    Time frame: 4 months

    Hospital Anxiety and Depression Scale (HADS)

  6. Change from baseline depression score at 4 months

    Time frame: 4 months

    Hospital Anxiety and Depression Scale (HADS)

  7. Change from baseline self-efficacy score at 4 months

    Time frame: 4 months

    Self Efficacy Exercise Scale (SEE-SV)

  8. Change from baseline health-related quality of life score at 4 months

    Time frame: 4 months

    Short-Form-36 (SF-36)

  9. Change from baseline health-related quality of life score at 4 months

    Time frame: 4 months

    EQ5D

  10. Change from baseline level of physical activity at 4 months

    Time frame: 4 months

    Accelerometer

  11. Change from baseline level of physical activity at 4 months

    Time frame: 4 months

    Bouchard questionnaire

  12. Change from baseline aerobic exercise capacity (watts) at 12 months

    Time frame: 12 months

    Submaximal exercise test on bicycle ergometer

  13. Adherence to dose of exercise

    Time frame: 12 months

    Accelerometer

  14. Adherence to dose of exercise

    Time frame: 12 months

    Exercise diary

  15. Change from baseline unilateral isotonic shoulder flexion (repetitions) at 12 months

    Time frame: 12 months

    Muscle endurance test

  16. Change from baseline unilateral isotonic heel lift (repetitions) at 12 months

    Time frame: 12 months

    Muscle endurance test

  17. Change from baseline anxiety score at 12 months

    Time frame: 12 months

    Hospital Anxiety and Depression Scale (HADS)

  18. Change from baseline depression score at 12 months

    Time frame: 12 months

    Hospital Anxiety and Depression Scale (HADS)

  19. Change from baseline self-efficacy score at 12 months

    Time frame: 12 months

    Self Efficacy Exercise Scale (SEE-SV)

  20. Change from baseline health-related quality of life score at 12 months

    Time frame: 12 months

    Short-Form-36 (SF-36)

  21. Change from baseline health-related quality of life score at 12 months

    Time frame: 2 months

    EQ5D

  22. Change from baseline level of physical activity at 12 months

    Time frame: 12 months

    accelerometer

  23. Change from baseline level of physical activity at 12 months

    Time frame: 12 months

    Bouchard questionnaire

  24. Patient Enablement (score)

    Time frame: 12 months

    Patient Enablement Instrument (PEI)

Sponsors and collaborators

Lead sponsor

Linkoeping University

Other Gov

Registry information

Acronym: ECRA

Important dates

Study start
2016
Primary completion
2019
Study completion
2021
First posted
Sep 9, 2016
Registry last updated
Oct 18, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.